<乌鸦传媒>Keeping Plavix After Short DAPT: Bleeding Benefit Emerges a Few Years After PCI Antiplatelet strategy has good results in longer follow-up of SMART-CHOICE trial Sep 29, 2022
<乌鸦传媒>Brief Anticoagulation Preserves Radial Artery After Catheter Access Trial shows promise of a short course of direct-acting oral anticoagulant Sep 20, 2022
<乌鸦传媒>PCI vs CABG: Does Age Inform Choice for Left Main Coronary Artery Disease? Swedish registry study contributes to ongoing controversy Sep 19, 2022
<乌鸦传媒>Pulmonary Artery Denervation Improves PAH Symptoms Trial promising for novel technique Sep 19, 2022
<乌鸦传媒>RDN Powers Through Another Off-Med Trial, Clinical Benefits Still Untested Plus, an apparent magnification of effect in SYMPLICITY HTN-3 Sep 19, 2022
<乌鸦传媒>PCI Not (Much) Worse Than CABG for Multivessel Disease Long Term Extended follow-up of BEST trial appeared unlikely to change minds, though Sep 19, 2022
<乌鸦传媒>Ultrasound Guidance No Advantage for PCI Access But randomized trial still suggests some reasons to consider this readily available intervention Sep 18, 2022
<乌鸦传媒>MitraClip G4 Sets the Bar Higher for Transcatheter Edge-to-Edge Repair Post-approval study suggests growing pool of TEER-suitable patients Sep 18, 2022
<乌鸦传媒>Clot Grabber Safe, Promising in Intermediate-Risk PE Registry supports expanding use of interventional treatment Sep 18, 2022
<乌鸦传媒>Is TAVR in Small Aortic Annuli Better With Self-Expanding Valves? Registry supports mortality impact of patient-prosthesis mismatch Sep 17, 2022
<乌鸦传媒>Mitral Valve Repair Devices Go Head-to-Head, and the Top Spot Belongs to... CLASP IID trial crowns no winner but champions expanding choices Sep 17, 2022
<乌鸦传媒>Presumed Clinical Benefits of TAVR Cerebral Protection Remain Unproven Large trial comes up short in proving a definitive benefit to debris filters Sep 17, 2022
<乌鸦传媒>Aggressive Alcohol Septal Ablation for HCM Holds Up, Pacemakers Notwithstanding Complication of ablation not associated with worse outcomes at 5 years Sep 14, 2022
<乌鸦传媒>Milestone Reached for SGLT2 Inhibitor Aimed at Heart Attack Population Good signals in people with large acute MIs at risk of developing heart failure Aug 30, 2022
<乌鸦传媒>Transradial Access for Heart Procedures Saves Lives in Most Definitive Study Yet Approach beats coronary access through the thigh Aug 29, 2022
<乌鸦传媒>Pendulum Swings Back for FFR-Guided Complete Revascularization Modality helps avoid unnecessary intervention in heart attack patients with multivessel disease Aug 29, 2022
<乌鸦传媒>Perfusion Tests Comparable as Second-Line Diagnostic for Chest Pain Head-to-head trial finds "interchangeable" accuracy Aug 29, 2022
<乌鸦传媒>Routine Stress Testing Didn't Offer Benefits to High-Risk Patients Post-PCI South Korean trial showed no improvement in clinical outcomes at 2 years Aug 28, 2022
<乌鸦传媒>Extravascular ICD Gains Ground in Unfamiliar Territory Inappropriate shocks among early challenges of device therapy under the sternum Aug 28, 2022
<乌鸦传媒>PCI Flops for Ischemic LV Dysfunction With Coronary Artery Disease Randomized trial provides "definitive" evidence against revascularizing stable cases Aug 27, 2022
<乌鸦传媒>How to Avoid the Unnecessary Cardiovascular Operations of Philip Roth's 'Everyman' The Skeptical Cardiologist discusses the book's lessons for patients Aug 21, 2022
<乌鸦传媒>Paxlovid-Heart Drug Interactions; Turkish Cardiologist Murdered; Permanent PCSK9i? Recent developments of interest in cardiovascular medicine Jul 12, 2022
<乌鸦传媒>Surgery After TAVR: Waiting a Month or More Not Really Better Prosthesis-patient mismatch, paravalvular regurgitation the bigger issues for surgical candidates Jul 08, 2022
<乌鸦传媒>Hearts in Extreme Heat; Pandemic's Heart Transplant Policies; Entresto Titration Recent developments of interest in cardiovascular medicine Jun 21, 2022
<乌鸦传媒>TAVR Pacemaker Rate Dips to Single Digits Nationwide, but Outlier Hospitals Remain Do worst-performing sites need more education about best practices? Jun 12, 2022
<乌鸦传媒>Fate of Transcatheter Tricuspid Devices: Will it Be Repair or Replacement? Many unanswered questions remain regarding devices for tricuspid regurgitation Jun 11, 2022
<乌鸦传媒>TAVR Devices Keep Changing -- Is This Really Helping Patients? Clinical outcomes are headed in the right direction, but better research is needed Jun 10, 2022
<乌鸦传媒>Promising First Dips Into a Bigger Pool of MitraClip Candidates Real-world outcomes in people with secondary MR who don't fit COAPT criteria Jun 09, 2022
<乌鸦传媒>Paclitaxel Devices Safe in PAD In Medicare Data Beyond 3 Years SAFE-PAD study update doesn't support excess mortality risk May 21, 2022
<乌鸦传媒>Chronic Total Occlusion PCI Is Getting Safer -- At Least Until the Pandemic Registry illuminates trends in success, complications May 21, 2022
<乌鸦传媒>TAVR for Aortic Regurgitation Off to a Good Start in the Real World Yet some growing pains remain for the Jenavalve Trilogy May 21, 2022
<乌鸦传媒>No-Implant Shunt Eases HF Symptoms in Early Data Quality of life consistently improved across first-in-man studies May 20, 2022
<乌鸦传媒>Device Type Matters for Valve-in-Valve TAVR in Small Anatomies Showdown between Sapien and Evolut valves in the LYTEN trial May 20, 2022
<乌鸦传媒>Lithotripsy Advantage in Calcified Peripheral Vessels Holds Up at 1 Year Disrupt PAD III trial extends superiority over percutaneous transluminal angioplasty May 19, 2022
<乌鸦传媒>Distal Radial Artery PCI Access Doesn't Hurt the Hand Randomized trial answers questions on grip, pinch, and other hand outcomes May 19, 2022
<乌鸦传媒>TAVR Stays Its Course as 10-Year Durability Data Trickle In Glimpse of longer-term valve degeneration in early TAVR patients May 19, 2022
<乌鸦传媒>PFO Closure Guidelines Address Older Adults, Trial-Excluded Groups Document acknowledges skimpy evidence May 19, 2022
<乌鸦传媒>Fancy Coronary Access Technique Disappoints in Preventing Radial Artery Occlusions Distal radial approach did result in easier hemostasis, however May 18, 2022
<乌鸦传媒>Renal Denervation Responders Hint at Good Clinical Outcomes A taste of clinical outcomes data when a randomized trial is unlikely May 17, 2022
